LBF20207PG29: Difference between revisions
No edit summary |
No edit summary |
||
Line 5: | Line 5: | ||
|LipidMaps=LMFA03010024 | |LipidMaps=LMFA03010024 | ||
|SysName=9-oxo-11alpha,15S,19R-trihydroxy-prosta-5Z,13E-dien-1-oic acid | |SysName=9-oxo-11alpha,15S,19R-trihydroxy-prosta-5Z,13E-dien-1-oic acid | ||
|Common Name=&&19 (R) -hydroxy Prostaglandin E_2&& | |Common Name=&&19 (R) -hydroxy Prostaglandin E_2&&9-oxo-11alpha,15S,19R-trihydroxy-prosta-5Z,13E-dien-1-oic acid&& | ||
}} | }} |
Revision as of 00:01, 20 December 2008
IDs and Links | |
---|---|
LipidBank | XPR1713 |
LipidMaps | LMFA03010024 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG29 |
19 (R) -hydroxy Prostaglandin E2 | |
---|---|
Structural Information | |
9-oxo-11α,15S,19R-trihydroxy-prosta-5Z,13E-dien-1-oic acid | |
| |
Formula | C20H32O6 |
Exact Mass | 368.219888756 |
Average Mass | 368.46448 |
SMILES | [C@H]([C@@H](C=C[C@H](O)CCC[C@@H](C)O)1)(C(C[C@H]1O)=O)CC=CCCCC(O)=O |
Physicochemical Information | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|